UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 15, 2019

 

Applied BioSciences Corp.

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other jurisdiction of incorporation)

 

000-55523

(Commission File Number)

 

81-1699502

(IRS Employer Identification No.)

 

9701 Wilshire Blvd., Suite 1000

Beverly Hills, California 90212

(Address of principal executive offices)(Zip Code)

 

(310) 356-7374

Registrant’s telephone number, including area code

 

______________________________________________

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 
 
 

 

ITEM 2.02 Results of Operations and Financial Condition.

 

On August 15, 2019, Applied BioSciences Corp. issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

ITEM 9.01 Financial Statements and Exhibits.

 

99.1 Press release dated August 15, 2019

 

 

2

 
 

 

SIGNATURE PAGE

 

Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Applied BioSciences Corp.

 

Dated: August 15, 2019

By:

/s/ Raymond W. Urbanski

Raymond W. Urbanski

Chief Executive Officer

 

 

3

 

Applied Biosciences (CE) (USOTC:APPB)
Historical Stock Chart
Von Okt 2024 bis Nov 2024 Click Here for more Applied Biosciences (CE) Charts.
Applied Biosciences (CE) (USOTC:APPB)
Historical Stock Chart
Von Nov 2023 bis Nov 2024 Click Here for more Applied Biosciences (CE) Charts.